Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jun 2026 for Axsome Therapeutics, Inc., €64k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mahony Susan: trading record in brief
All filings by Mahony Susan on record concern Axsome Therapeutics, Inc. In total, 2 filings cover trades dated from 9 June 2026 to 10 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 10 June 2026 came the latest disclosure, a transaction for €64k in Axsome Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mahony Susan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
300 shares@ US$246.18CommonSEC144:0001921094-26-000633
300 shares@ US$237.21CommonSEC144:0001921094-26-000618
2 of 2 declarations
